Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic HER2-Negative Breast Carcinoma|Metastatic Triple-Negative Breast Carcinoma
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Biospecimen Collection|BIOLOGICAL: Sacituzumab Govitecan
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)